-
Pfizer's Options: A Look at What the Big Money is Thinking
27 Mar 2024 18:12 GMT
… .0K
586
410
About Pfizer
Pfizer is one of the … and cardiovascular treatment Eliquis. Pfizer sells these products globally, …
Present Market Standing of Pfizer
Currently trading with a … be approaching overbought.
Anticipated earnings release is in 35 days …
-
Syros Pharmaceuticals, Inc. (SYRS) Q4 2023 Earnings Call Transcript
27 Mar 2024 16:02 GMT
… , Inc. (NASDAQ:SYRS) Q4 2023 Earnings Conference Call March 27, 2024 … of the collaboration agreement with Pfizer-GBT in October 2023. R …
-
Moleculin Biotech, Inc. (MBRX) Q4 2023 Earnings Call Transcript
25 Mar 2024 16:29 GMT
… , Inc. (NASDAQ:MBRX) Q4 2023 Earnings Conference Call March 25, 2024 … , right? Look, if we were Pfizer, we probably would do exactly …
-
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
28 Mar 2024 20:05 GMT
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis in their own lab, …
-
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
27 Mar 2024 20:01 GMT
Gained global registrational clarity for naporafenib and achieved key clinical milestones for naporafenib, ERAS-007, and ERAS-801
Multiple data readouts expected in 2024 for naporafenib (SEACRAFT-1), ERAS-007 (HERKULES-3), and ERAS-801 (THUNDERBBOLT-1) and …
-
eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
25 Mar 2024 20:01 GMT
Topline data from the randomized Phase 2b KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer (NSCLC) expected in early April 2024
Median progression free survival (mPFS) of 7.4 months in the ZFA expansion cohort …
-
IVV: The S&P 500 Is Not Expensive
29 Mar 2024 02:28 GMT
… and that have had positive earnings in the last four quarters … require analyst valuation upgrades on earnings improvement as well as lower … and provide a more realistic earnings view. As can be … , LLY, Amazon, Uber, and Pfizer (PFE). SPX Valuation (Created by …
-
20 Best Stocks to Buy Right Now According to Financial Media
28 Mar 2024 19:18 GMT
… of our estimate of normalized earnings, Cisco is trading comfortably … Picks of Financial Media: 3 Pfizer Inc. (NYSE:PFE) discovers, … in Q4 were BorgWarner and Pfizer Inc. (NYSE:PFE). Biopharmaceutical … . We continue to like Pfizer for its diversified business, …
-
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
28 Mar 2024 12:55 GMT
… the bottom. Although tied with Pfizer for the vaccine rollout, it … by reporting positive $0.55 earnings per share (EPS) vs expected … .
In the latest Q2 FY24 earnings, Bio-Techne reported $272.6 …
-
Biopharma Layoffs Roundup
27 Mar 2024 17:18 GMT
… ’s larger firms, including Pfizer, Roche, Takeda, and … and Comirnaty sales globally, Pfizer implemented an enterprise-wide … manufacturing site in the Pfizer network, this facility manufactures …
In its first-quarter earnings report, Novavax announced plans to …